Admedus has been in a downtrend since September 2014, apart from an end of the year rally to 14 cents.
The share price appears to have bottomed at 7.1 cents, and has now started an impusive move higher which is testing resistance at the trend line.
This lift seems to have been triggered by a report of a new product based on the ADAPT technology, for neurosurgical use. Preclinical testing has been carried out over the past month, but has been encouraging.
The expectation is that if this move continues it will test resistance at 10.5 cents.
The next resistance level would be 14 cents.
If this is overcome, my longer term target of 20 cents might then come into focus.
Admedus has been in a downtrend since September 2014, apart from...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.22 |
Change
0.740(6.45%) |
Mkt cap ! $258.3M | |||
| Open | High | Low | Value | Volume |
| $11.50 | $12.25 | $11.49 | $395.2K | 33.29K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100 | $11.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.22 | 127 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |